Central Blood Pressure is the best predictor of cardiovascular risk!
Cardiologist Dr. Hunter Champion uses SphygmoCor® XCEL to target medications and optimize hypertension care
“ We need simple individualized guidelines based on central pressure. ”
—Cardiology Today
“ Precise measurement of cBP improves patient management decisions in hypertension. ”
—Lancet Commission on Hypertension
“ I use SphygmoCor in my preventive cardiology practice—it’s an integral component of my cardiovascular risk assessment. ”
—Lee Marcus MD, MS, FACC
What's new in Central Blood Pressure?
Managing Hypertension Using Central Blood Pressure Analysis
What is Central Blood Pressure and Why Does It Matter?
Health Economics Impact of ATCOR Central Blood Pressure Technology
The only cure for dementia is prevention.
Central blood pressure (cBP) and arterial stiffness may be early indicators of Alzheimer’s and other causes of dementia.1,2
ATCOR noninvasive central blood pressure and pulse wave analysis enable clinicians to identify high-risk patients and target therapies to delay or prevent dementia.
SphygmoCor® by the numbers
All “Top 20 Hospitals” use SphygmoCor® technology to measure central blood pressure (cBP)
4,000+ studies using the SphygmoCor® technology have been published in peer-reviewed clinical publications.
8 out of Top 10 Pharma companies have used SphygmoCor® technology in their clinical trials
Over 11,000 patients have been tested with SphygmoCor® technology in pharmaceutical trials